Leerink Partnrs Issues Negative Forecast for ARDT Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Equities research analysts at Leerink Partnrs cut their Q1 2025 EPS estimates for shares of Ardent Health Partners in a research report issued to clients and investors on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $0.20 per share for the quarter, down from their previous estimate of $0.33. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q2 2025 earnings at $0.61 EPS.

Other analysts also recently issued reports about the company. Truist Financial cut their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Stephens reaffirmed an “overweight” rating and set a $22.00 target price on shares of Ardent Health Partners in a research report on Tuesday. Morgan Stanley lowered their target price on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 21st. Royal Bank of Canada decreased their price objective on Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a report on Tuesday, March 4th. Finally, JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $20.00 price target on shares of Ardent Health Partners in a report on Tuesday, December 17th. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $21.18.

Ardent Health Partners Price Performance

Shares of ARDT stock opened at $12.22 on Friday. Ardent Health Partners has a 12-month low of $12.13 and a 12-month high of $20.72. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.78 and a current ratio of 1.91. The firm has a 50 day moving average price of $14.25 and a two-hundred day moving average price of $16.07.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion.

Institutional Trading of Ardent Health Partners

Several hedge funds and other institutional investors have recently bought and sold shares of ARDT. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Ardent Health Partners in the 4th quarter worth approximately $27,000. US Bancorp DE bought a new position in shares of Ardent Health Partners during the fourth quarter valued at about $31,000. R Squared Ltd bought a new position in shares of Ardent Health Partners during the fourth quarter valued at about $37,000. BNP Paribas Financial Markets purchased a new stake in shares of Ardent Health Partners during the third quarter worth about $42,000. Finally, New York State Common Retirement Fund bought a new stake in shares of Ardent Health Partners in the fourth quarter worth about $48,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.